Drug Maker Agrees To Pay $95M To Settle Federal Securities Law Claims

Mealey's (July 22, 2016, 12:13 PM EDT) -- LOS ANGELES — A drug maker will pay $95 million to settle claims that it misrepresented certain safety concerns with two of its products in violation of federal securities laws, according...

To view the full article, register now.